Teresa McCarthy - May 11, 2021 Form 3 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Chief Human Resources Officer
Signature
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Stock symbol
RNA
Transactions as of
May 11, 2021
Transactions value $
$0
Form type
3
Date filed
5/20/2021, 03:34 PM
Next filing
Mar 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNA Stock Option (Right to Buy) May 11, 2021 Common Stock 106K $29.00 Direct F1
holding RNA Stock Option (Right to Buy) May 11, 2021 Common Stock 110K $22.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on August 24, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F2 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 1, 2021 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.